WishBone Medical Inc. Acquires New Jersey’s Response Ortho
November 28, 2018 at 6:55 p.m.
WishBone Medical Inc. Acquires New Jersey’s Response Ortho
By Staff Report-
Response Ortho has a complete pediatric line of external and internal fixation and deformity correction products. The company has been in business for 14 years and has built a high-tech manufacturing facility with access to an experienced engineering and technical labor force.
[[In-content Ad]]
Product development and launch activities have been dramatically accelerated for WishBone Medical with the Response Ortho offering of over 30 developed pediatric orthopedic systems, with multiple patents. These include the award-winning “Smart Correction” Hexapod Fixator and “Click2Correct” surgical preoperative planning software.
Eighteen of the product systems can be sold in the United States, and Response Ortho is working on Food and Drug Administration clearance for the remaining products.
The company has committed to providing global access to anatomically appropriate implants and instruments in sterile packed, single-use disposable kits for children.
Nick Deeter, chairman of the board and CEO at WishBone Medical, said, “With the acquisition of Response Ortho, we are thrilled about our pediatric orthopedic product offerings. The combination of Response Ortho’s 30 product systems and WishBone’s eight product systems will give WishBone Medical the broadest product portfolio in pediatric orthopedics worldwide.
“These pediatric orthopedic products can be delivered in sterile packed, procedural kits anywhere in the world, next day, to the surgeons that care for children.”
Sehmuz Isin, CEO of Response Ortho said, “We are excited that Response Ortho is now part of WishBone Medical. Our primary focus has been outside the U.S., and we will now be able to offer these innovative orthopedic product systems everywhere. Having more than 50 years of combined experience, Nick and I understand the unmet needs and will provide global solutions to children with orthopedic issues.”
A press release by WishBone didn’t indicate the cost of the acquisition or when the transaction would be final.
Response Ortho has a complete pediatric line of external and internal fixation and deformity correction products. The company has been in business for 14 years and has built a high-tech manufacturing facility with access to an experienced engineering and technical labor force.
[[In-content Ad]]
Product development and launch activities have been dramatically accelerated for WishBone Medical with the Response Ortho offering of over 30 developed pediatric orthopedic systems, with multiple patents. These include the award-winning “Smart Correction” Hexapod Fixator and “Click2Correct” surgical preoperative planning software.
Eighteen of the product systems can be sold in the United States, and Response Ortho is working on Food and Drug Administration clearance for the remaining products.
The company has committed to providing global access to anatomically appropriate implants and instruments in sterile packed, single-use disposable kits for children.
Nick Deeter, chairman of the board and CEO at WishBone Medical, said, “With the acquisition of Response Ortho, we are thrilled about our pediatric orthopedic product offerings. The combination of Response Ortho’s 30 product systems and WishBone’s eight product systems will give WishBone Medical the broadest product portfolio in pediatric orthopedics worldwide.
“These pediatric orthopedic products can be delivered in sterile packed, procedural kits anywhere in the world, next day, to the surgeons that care for children.”
Sehmuz Isin, CEO of Response Ortho said, “We are excited that Response Ortho is now part of WishBone Medical. Our primary focus has been outside the U.S., and we will now be able to offer these innovative orthopedic product systems everywhere. Having more than 50 years of combined experience, Nick and I understand the unmet needs and will provide global solutions to children with orthopedic issues.”
A press release by WishBone didn’t indicate the cost of the acquisition or when the transaction would be final.
Have a news tip? Email [email protected] or Call/Text 360-922-3092